Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00604097 · ClinicalTrials.gov registry record · Phase 3

Preventing Youth Suicide in Primary Care: A Family Model

A Phase 3 study of Suicide, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
Phase 3
Development phase
66
Enrollment target
4
Study locations

NCT00604097 is a Phase 3 study of Suicide that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 66 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00604097, a Phase 3 study of Suicide, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
Phase 3
Development phase
66 participants
Enrollment target
4
Study locations

Study Summary

The purpose of the study is to test the efficacy of a brief family therapy (Attachment-Based Family Therapy) for youth presenting in primary care with suicidal ideation and depressed mood.

Conditions Studied

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL Attachment-Based Family Therapy

Study Locations (4)

Pennsylvania

  • CHOP Adolescent Care Center - Philadelphia
  • CHOP University City Primary Care - Philadelphia
  • CHOP Primary Care Center at Cobb's Creek - Philadelphia
  • CHOP Primary Care Center in South Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2004-09
Est. Completion 2008-08
Phase Phase 3

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT00604097

The ClinicalTrials.gov registry entry for NCT00604097 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT00604097 reports 4 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00604097 about?

NCT00604097 is a clinical study titled "Preventing Youth Suicide in Primary Care: A Family Model". The purpose of the study is to test the efficacy of a brief family therapy (Attachment-Based Family Therapy) for youth presenting in primary care with suicidal ideation and depressed mood.

What is the current status of trial NCT00604097?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 66 participants. The study started on 2004-09. Estimated completion is 2008-08.

What conditions does trial NCT00604097 study?

This clinical trial studies the following conditions: Suicide.

What interventions are being tested in trial NCT00604097?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Attachment-Based Family Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00604097?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00604097 being conducted?

This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.